The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
Open accessAbstract
Oncolytic viruses (OVs) are novel immunotherapeutic agents whose anticancer effects come from both oncolysis and elicited antitumor immunity. OVs induce mostly immunogenic cancer cell death (ICD), including immunogenic apoptosis, necrosis/necroptosis, pyroptosis, and autophagic cell death, leading to exposure of calreticulin and heat-shock proteins to the cell surface, and/or released ATP, high-mobility group box 1, uric acid, and other damage-associated molecular patterns as well as pathogen-associated molecular patterns as danger signals, along with tumor-associated antigens, to activate dendritic cells and elicit adaptive antitumor immunity. Dying the right way may greatly potentiate adaptive antitumor immunity. The mode of cancer cell death may be modulated by individual OVs and cancer cells as they often encode and express genes that inhibit/promote apoptosis, necroptosis, or autophagic cell death. We can genetically engineer OVs with death-pathway-modulating genes and thus skew the infected cancer cells toward certain death pathways for the enhanced immunogenicity. Strategies combining with some standard therapeutic regimens may also change the immunological consequence of cancer cell death. In this review, we discuss recent advances in our understanding of danger signals, modes of cancer cell death induced by OVs, the induced danger signals and functions in eliciting subsequent antitumor immunity. We also discuss potential combination strategies to target cells into specific modes of ICD and enhance cancer immunogenicity, including blockade of immune checkpoints, in order to break immune tolerance, improve antitumor immunity, and thus the overall therapeutic efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Approaching the Asymptote? Evolution and Revolution in Immunology
Janeway, C. A. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,252
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Decoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
How dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377
PAMP s and DAMP s: signal 0s that spur autophagy and immunity
Tang, D., Kang, R., Coyne, C. B., Zeh, H. J., & Lotze, M. T. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01146.x · Cited by 1,221
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
Unveiling the roles of autophagy in innate and adaptive immunity
Levine, B., & Deretic, V. (2007) · Nature Reviews Immunology · doi:10.1038/nri2161 · Cited by 906
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
Debbas, M., & White, E. (1993) · Genes & Development · doi:10.1101/gad.7.4.546 · Cited by 871
HSV-1 ICP34.5 Confers Neurovirulence by Targeting the Beclin 1 Autophagy Protein
Orvedahl, A., Alexander, D., Tallóczy, Z., Sun, Q., Wei, Y., Zhang, W., Burns, D., Leib, D. A., & Levine, B. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2006.12.001 · Cited by 857
Heo, J., Reid, T., Ruo, L., Breitbach, C. J., Rose, S., Bloomston, M., Cho, M., Lim, H. Y., Chung, H. C., Kim, C. W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3089 · Cited by 779
HMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762
Zamarin, D., Holmgaard, R. B., Subudhi, S. K., Park, J. S., Mansour, M., Palese, P., Merghoub, T., Wolchok, J. D., & Allison, J. P. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008095 · Cited by 711
Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2
Scheibner, K. A., Lutz, M. A., Boodoo, S., Fenton, M. J., Powell, J. D., & Horton, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1272 · Cited by 708
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation
Krysko, D. V., Agostinis, P., Krysko, O., Garg, A. D., Bachert, C., Lambrecht, B. N., & Vandenabeele, P. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.005 · Cited by 680
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.
Lowe, S. W., & Ruley, H. E. (1993) · Genes & Development · doi:10.1101/gad.7.4.535 · Cited by 666
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins
Dengjel, J., Schoor, O., Fischer, R., Reich, M., Kraus, M., Müller, M., Kreymborg, K., Altenberend, F., Brandenburg, J., Kalbacher, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501190102 · Cited by 658
Inflammatory signals in dendritic cell activation and the induction of adaptive immunity
Joffre, O., Nolte, M. A., Spörri, R., & Sousa, C. R. E. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00718.x · Cited by 598
Virus Inhibition of RIP3-Dependent Necrosis
Upton, J. W., Kaiser, W. J., & Mocarski, E. S. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.03.006 · Cited by 559
Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with Lysosomes
Gannagé, M., Dormann, D., Albrecht, R., Dengjel, J., Torossi, T., Rämer, P. C., Lee, M., Strowig, T., Arrey, F., Conenello, G., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.09.005 · Cited by 526
Molecular characteristics of immunogenic cancer cell death
Tesniere, A., Panaretakis, T., Kepp, O., Apetoh, L., Ghiringhelli, F., Zitvogel, L., & Kroemer, G. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402269 · Cited by 494
English, L., Chemali, M., Duron, J., Rondeau, C., Laplante, A., Gingras, D., Alexander, D., Leib, D., Norbury, C., Lippé, R., et al. (2009) · Nature Immunology · doi:10.1038/ni.1720 · Cited by 459
Manipulation of Host Cell Death Pathways during Microbial Infections
Lamkanfi, M., & Dixit, V. M. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.007 · Cited by 454
Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., & Vile, R. G. (1998) · Nature Medicine · doi:10.1038/nm0598-581 · Cited by 445
Chou, J., & Roizman, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3266 · Cited by 393
Shikonin circumvents cancer drug resistance by induction of a necroptotic death
Han, W., Li, L., Qiu, S., Lu, Q., Pan, Q., Gu, Y., Luo, J., & Hu, X. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0511 · Cited by 364
White, E., Sabbatini, P., Debbas, M., Wold, W. S. M., Kusher, D. I., & Gooding, L. R. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2570-2580.1992 · Cited by 349
Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
Inoue, H., & Tani, K. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.84 · Cited by 347
Tolerance, Danger and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.991 · Cited by 335
Oncolytic viruses as therapeutic cancer vaccines
Bartlett, D. L., Liu, Z., Sathaiah, M., Ravindranathan, R., Guo, Z., He, Y., & Guo, Z. S. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-103 · Cited by 324
Self-citationImmunogenic cancer cell death: a key-lock paradigm
Tesniere, A., Apetoh, L., Ghiringhelli, F., Joza, N., Panaretakis, T., Kepp, O., Schlemmer, F., Zitvogel, L., & Kroemer, G. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.007 · Cited by 307
Efficient Cross-presentation Depends on Autophagy in Tumor Cells
Li, Y., Wang, L.-X., Yang, G., Hao, F., Urba, W. J., & Hu, H.-M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0161 · Cited by 303
Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow
Breitbach, C. J., Paterson, J. M., Lemay, C. G., Falls, T. J., McGuire, A., Parato, K. A., Stojdl, D. F., Daneshmand, M., Speth, K., Kirn, D., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300215 · Cited by 277
Autophagy regulates selective HMGB1 release in tumor cells that are destined to die
Thorburn, J., Horita, H., Redzic, J., Hansen, K., Frankel, A. E., & Thorburn, A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.143 · Cited by 268
Oncolytic Immunovirotherapy for Melanoma Using Vesicular Stomatitis Virus
Diaz, R. M., Galivo, F., Kottke, T., Wongthida, P., Qiao, J., Thompson, J., Valdes, M., Barber, G., & Vile, R. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3974 · Cited by 264
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
Breitbach, C. J., Arulanandam, R., De Silva, N., Thorne, S. H., Patt, R., Daneshmand, M., Moon, A., Ilkow, C., Burke, J., Hwang, T.-H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2687 · Cited by 258
Newcastle Disease Virus V Protein Is a Determinant of Host Range Restriction
Park, M.-S., García-Sastre, A., Cros, J. F., Basler, C. F., & Palese, P. (2003) · Journal of Virology · doi:10.1128/jvi.77.17.9522-9532.2003 · Cited by 243
VIRAL ONCOLYSIS: INCREASED IMMUNOGENICITY OF HOST CELL ANTIGEN ASSOCIATED WITH INFLUENZA VIRUS
Lindenmann, J., & Klein, P. A. (1967) · The Journal of Experimental Medicine · doi:10.1084/jem.126.1.93 · Cited by 232
Miyamoto, S., Inoue, H., Nakamura, T., Yamada, M., Sakamoto, C., Urata, Y., Okazaki, T., Marumoto, T., Takahashi, A., Takayama, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3185 · Cited by 222
Herpes Simplex Virus Inhibits Apoptosis through the Action of Two Genes, Us5 and Us3
Jerome, K. R., Fox, R., Chen, Z., Sears, A. E., Lee, H.-Y., & Corey, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.8950-8957.1999 · Cited by 221
Nucleosomes Are Exposed at the Cell Surface in Apoptosis
Radic, M., Marion, T., & Monestier, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6692 · Cited by 218
Kaufman, H. L., & Bines, S. D. (2010) · Future Oncology · doi:10.2217/fon.10.66 · Cited by 209
Workenhe, S. T., & Mossman, K. L. (2014) · Molecular Therapy · doi:10.1038/mt.2013.220 · Cited by 203
Uhl, M., Kepp, O., Jusforgues-Saklani, H., Vicencio, J.-M., Kroemer, G., & Albert, M. L. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.8 · Cited by 196
Reovirus-Induced Apoptosis Is Mediated by TRAIL
Clarke, P., Meintzer, S. M., Gibson, S., Widmann, C., Garrington, T. P., Johnson, G. L., & Tyler, K. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8135-8139.2000 · Cited by 195
Perez, D., & White, E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00013-4 · Cited by 193
Guo, Z. S., Thorne, S. H., & Bartlett, D. L. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.02.001 · Cited by 192
Self-citationLiu, T.-C., Hwang, T., Park, B.-H., Bell, J., & Kirn, D. H. (2008) · Molecular Therapy · doi:10.1038/mt.2008.143 · Cited by 189
Measles virus causes immunogenic cell death in human melanoma
Donnelly, O. G., Errington-Mais, F., Steele, L., Hadac, E., Jennings, V, Scott, K., Peach, H., Phillips, R. M., Bond, J., Pandha, H., et al. (2013) · Gene Therapy · doi:10.1038/gt.2011.205 · Cited by 187
Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity
Errington, F., Steele, L., Prestwich, R., Harrington, K. J., Pandha, H. S., Vidal, L., de Bono, J., Selby, P., Coffey, M., Vile, R., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6018 · Cited by 186
Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
Prestwich, R. J., Errington, F., Ilett, E. J., Morgan, R. S. M., Scott, K. J., Kottke, T., Thompson, J., Morrison, E. E., Harrington, K. J., Pandha, H. S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0831 · Cited by 184
Prestwich, R. J., Ilett, E. J., Errington, F., Diaz, R. M., Steele, L. P., Kottke, T., Thompson, J., Galivo, F., Harrington, K. J., Pandha, H. S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0334 · Cited by 184
Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus
Kanerva, A., Nokisalmi, P., Diaconu, I., Koski, A., Cerullo, V., Liikanen, I., Tähtinen, S., Oksanen, M., Heiskanen, R., Pesonen, S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2546 · Cited by 177
Autophagic Cell Death of Malignant Glioma Cells Induced by a Conditionally Replicating Adenovirus
Ito, H., Aoki, H., Kühnel, F., Kondo, Y., Kubicka, S., Wirth, T., Iwado, E., Iwamaru, A., Fujiwara, K., Hess, K. R., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj161 · Cited by 175
Cooray, S., Bahar, M. W., Abrescia, N. G. A., McVey, C. E., Bartlett, N. W., Chen, R. A.-J., Stuart, D. I., Grimes, J. M., & Smith, G. L. (2007) · Journal of General Virology · doi:10.1099/vir.0.82772-0 · Cited by 172
T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy
Yu, F., Wang, X., Guo, Z. S., Bartlett, D. L., Gottschalk, S. M., & Song, X.-T. (2014) · Molecular Therapy · doi:10.1038/mt.2013.240 · Cited by 170
Self-citationTapia, K., Kim, W.-K., Sun, Y., Mercado-López, X., Dunay, E., Wise, M., Adu, M., & López, C. B. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003703 · Cited by 165
Liikanen, I., Ahtiainen, L., Hirvinen, M. L., Bramante, S., Cerullo, V., Nokisalmi, P., Hemminki, O., Diaconu, I., Pesonen, S., Koski, A., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.51 · Cited by 165
Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product
Dobbelstein, M., & Shenk, T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6479-6485.1996 · Cited by 165
Diaconu, I., Cerullo, V., Hirvinen, M. L. M., Escutenaire, S., Ugolini, M., Pesonen, S. K., Bramante, S., Parviainen, S., Kanerva, A., Loskog, A. S. I., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2975 · Cited by 162
Analysis of the Role of Autophagy in Replication of Herpes Simplex Virus in Cell Culture
Alexander, D. E., Ward, S. L., Mizushima, N., Levine, B., & Leib, D. A. (2007) · Journal of Virology · doi:10.1128/jvi.01356-07 · Cited by 155
Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy
Li, Y., Wang, L., Pang, P., Cui, Z.-H., Aung, S., Haley, D. P., Fox, B. A., Urba, W. J., & Hu, H. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0951 · Cited by 145
Immunogenecity signals 1,2,3... and 0
Janeway, C. A. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90081-9 · Cited by 140
Duran, G. A., Krysko, D. V., Kaczmarek, A., Petrovski, G., Vandenabeele, P., & Fésüs, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040069 · Cited by 139
Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer
Li, J., O’Malley, M. E., Urban, J. A., Sampath, P., Guo, Z. S., Kaliński, P., Thorne, S. H., & Bartlett, D. L. (2011) · Molecular Therapy · doi:10.1038/mt.2010.312 · Cited by 131
Self-citationAlonso, M. M., Jiang, H., Yokoyama, T., Xu, J., Bekele, N. B., Lang, F. F., Kondo, S., Gomez‐Manzano, C., & Fueyo-Margareto, J. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300400 · Cited by 126
Guo, Z. S., Naik, A. M., O’Malley, M. E., Popovič, P., DeMarco, R., Hu, Y., Yin, X., Yang, S., Zeh, H. J., Moss, B., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1630 · Cited by 126
Self-citationCassady, K. A., Gross, M. S., & Roizman, B. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7005-7011.1998 · Cited by 123
Workenhe, S. T., Simmons, G., Pol, J. G., Lichty, B. D., Halford, W. P., & Mossman, K. L. (2013) · Molecular Therapy · doi:10.1038/mt.2013.238 · Cited by 122
Adenoviruses induce autophagy to promote virus replication and oncolysis
Rodríguez‐Rocha, H., Gómez-Gutiérrez, J. G., García‐García, A., Rao, X., Chen, L., McMasters, K. M., & Zhou, H. S. (2011) · Virology · doi:10.1016/j.virol.2011.04.017 · Cited by 122
Oncolytic virus therapy for cancer: the first wave of translational clinical trials
Patel, M. R., & Kratzke, R. A. (2013) · Translational research · doi:10.1016/j.trsl.2012.12.010 · Cited by 119
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma
Errington‐Mais, F., White, C. L., Twigger, K. R., Rose, A., Scott, K. J., Steele, L. P., Ilett, E. J., Prestwich, R. J. D., Pandha, H. S., Coffey, M. C., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.58 · Cited by 115
John, L. B., Howland, L. J., Flynn, J. K., West, A. C., Devaud, C., Duong, C. P. M., Stewart, T. J., Westwood, J. A., Guo, Z. S., Bartlett, D. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2788 · Cited by 113
Self-citationEngineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways
Naik, S., & Russell, S. J. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903170653 · Cited by 112
Op, Z., & Klenk, H. (2013) · Journal of Virology · doi:10.1128/jvi.02148-13 · Cited by 111
Liu, P., Xu, B., Shen, W., Zhu, H., Wu, W., Fu, Y., Chen, H., Dong, H., Zhu, Y., Miao, K., et al. (2011) · Leukemia · doi:10.1038/leu.2011.357 · Cited by 111
Wang, Q., Imamura, R., Motani, K., Kushiyama, H., Nagata, S., & Suda, T. (2013) · International Immunology · doi:10.1093/intimm/dxs161 · Cited by 108
P2Y6 Receptor Signaling Pathway Mediates Inflammatory Responses Induced by Monosodium Urate Crystals
Uratsuji, H., Tada, Y., Kawashima, T., Kamata, M., Hau, C. S., Asano, Y., Sugaya, M., Kadono, T., Asahina, A., Sato, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003746 · Cited by 101
Wasilenko, S. T., Banadyga, L., Bond, D., & Barry, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14031-14043.2005 · Cited by 100
Cytolytic cells induce HMGB1 release from melanoma cell lines
Ito, N., DeMarco, R., Mailliard, R. B., Han, J., Rabinowich, H., Kaliński, P., Stolz, D. B., Zeh, H. J., & Lotze, M. T. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306169 · Cited by 100
Wongthida, P., Díaz, R. M., Galivo, F., Kottke, T. J., Thompson, J., Pulido, J. S., Pavelko, K. D., Pease, L. R., Melcher, A. A., & Vile, R. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4658 · Cited by 99
Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy
Sobol, P. T., Boudreau, J. E., Stephenson, K. B., Wan, Y., Lichty, B. D., & Mossman, K. L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.264 · Cited by 97
Endo, Y., Sakai, R., Ouchi, M., Onimatsu, H., Hioki, M., Kagawa, S., Uno, F., Watanabe, Y., Urata, Y., Tanaka, N., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210884 · Cited by 94
Chi, P. I., Huang, W., Lai, I., Cheng, C. Y., & Liu, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390245 · Cited by 92
Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
Meng, C., Zhou, Z., Jiang, K., Yu, S., Jia, L., Wu, Y., Liu, Y., Meng, S., & Ding, C. (2012) · Archives of Virology · doi:10.1007/s00705-012-1270-6 · Cited by 92
Reovirus Activates a Caspase-Independent Cell Death Pathway
Berger, A. K., & Danthi, P. (2013) · mBio · doi:10.1128/mbio.00178-13 · Cited by 86
Liu, T., Halldén, G., Wang, Y., Brooks, G., Francis, J., Lemoine, N., & Kirn, D. H. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.017 · Cited by 82
RNase L Triggers Autophagy in Response to Viral Infections
Chakrabarti, A., Ghosh, P. K., Banerjee, S., Gaughan, C., & Silverman, R. (2012) · Journal of Virology · doi:10.1128/jvi.00270-12 · Cited by 81
Life after death: targeting high mobility group box 1 in emergent cancer therapies.
Guo, Z. S., Liu, Z., Bartlett, D. L., Tang, D., & Lotze, M. T. (2013) · Europe PMC (PubMed Central) · Cited by 78
Self-citationHuang, B., Sikorski, R. P., Kirn, D. H., & Thorne, S. H. (2010) · Gene Therapy · doi:10.1038/gt.2010.121 · Cited by 76
Vaccinia Virus Induces Programmed Necrosis in Ovarian Cancer Cells
Whilding, L. M., Archibald, K. M., Kulbe, H., Balkwill, F. R., Öberg, D., & McNeish, I. A. (2013) · Molecular Therapy · doi:10.1038/mt.2013.195 · Cited by 76
Kim, M., Williamson, C. T., Prudhomme, J., Bebb, D. G., Riabowol, K. T., Lee, P. W. K., Lees‐Miller, S. P., Mori, Y., Rahman, M. M., McFadden, G., et al. (2010) · Oncogene · doi:10.1038/onc.2010.137 · Cited by 76
Angelova, A. L., Grekova, S. P., Heller, A., Kuhlmann, O., Soyka, E., Giese, T., Aprahamian, M., Bour, G., Rüffer, S., Cziepluch, C., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03688-13 · Cited by 76
Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer
Baird, S. K., Aerts, J. L., Eddaoudi, A., Lockley, M., Lemoine, N. R., & McNeish, I. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210977 · Cited by 75
Workenhe, S. T., Pol, J. G., Lichty, B. D., Cummings, D. T., & Mossman, K. L. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0059-t · Cited by 73
Comber, J. D., Robinson, T. M., Siciliano, N. A., Snook, A. E., & Eisenlohr, L. C. (2011) · Journal of Virology · doi:10.1128/jvi.02122-10 · Cited by 73
Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors
Zanoni, I., & Granucci, F. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0638-x · Cited by 68
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
Fournier, P., & Schirrmacher, V. (2013) · Biology · doi:10.3390/biology2030936 · Cited by 60
The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion
Zhou, J., Sun, X. Y., Fernando, G. J. P., & Frazer, I. H. (1992) · Virology · doi:10.1016/0042-6822(92)90591-c · Cited by 55
Alameda, J. P., Moreno-Maldonado, R., Navarro, M., Bravo, A., Ramírez, Á., Page, A., Jorcano, J. L., Fernández‐Aceñero, M. J., & Casanova, M. (2010) · Oncogene · doi:10.1038/onc.2010.378 · Cited by 55
Marcellus, R. C., Teodoro, J. G., Charbonneau, R., Shore, G. C., & Branton, P. E. (1996) · PubMed · Cited by 55
Moehler, M. H., Zeidler, M., Schede, J., Rommelaere, J., Galle, P. R., Cornelis, J. J., & Heike, M. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700591 · Cited by 54
Huang, P.-Y., Guo, J.-H., & Hwang, L. (2011) · Molecular Therapy · doi:10.1038/mt.2011.245 · Cited by 53
Colunga, A., Laing, J. M., & Aurelian, L. (2009) · Gene Therapy · doi:10.1038/gt.2009.126 · Cited by 53
Kim, H. S., Kim‐Schulze, S., Kim, D. W., & Kaufman, H. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2522 · Cited by 52
Reovirus modulates autophagy during oncolysis of multiple myeloma
Thirukkumaran, C. M., Shi, Z. Q., Luider, J. M., Kopciuk, K. A., Gao, H., Bahlis, N. J., Neri, P. E., Pho, M., Stewart, D., Mansoor, A., et al. (2013) · Autophagy · doi:10.4161/auto.22867 · Cited by 51
Stepwise Release of Biologically Active HMGB1 during HSV-2 Infection
Borde, C., Barnay‐Verdier, S., Gaillard, C., Hocini, H., Maréchal, V., & Gozlan, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016145 · Cited by 49
Schirrmacher, V. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1265 · Cited by 47
Padgett, J. J. (1994) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/0279-3695-19940101-04 · Cited by 47
Grekova, S. P., Aprahamian, M., Giese, N. A., Schmitt, S., Giese, T., Falk, C. S., Daeffler, L., Cziepluch, C., Rommelaere, J., & Raykov, Z. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.12.13455 · Cited by 44
Grekova, S. P., Raykov, Z., Zawatzky, R., Rommelaere, J., & Koch, U. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.20 · Cited by 42
Cheng, P.-H., Lian, S., Zhao, R., Rao, X., McMasters, K. M., & Zhou, H. S. (2013) · Virology Journal · doi:10.1186/1743-422x-10-293 · Cited by 41
Perez, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00007-1 · Cited by 41
Pathogen recognition by the cell surface receptor CD46 induces autophagy
Meiffren, G., Joubert, P.-E., Grégoire, I. P., Codogno, P., Rabourdin‐Combe, C., & Faure, M. (2010) · Autophagy · doi:10.4161/auto.6.2.11132 · Cited by 40
Young, A.-M., Archibald, K. M., Tookman, L. A., Pool, A., Dudek, K., Jones, C., Williams, S. L., Pirlo, K. J., Willis, A. E., Lockley, M., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.116 · Cited by 40
Wei, J., Waithman, J. C., Lata, R., Mifsud, N. A., Cebon, J. S., Kay, T. W. H., Smyth, M. J., Sadler, A. J., & Chen, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002129 · Cited by 32
Targeting autophagy to enhance oncolytic virus-based cancer therapy
Meng, S., Xu, J., Wu, Y., & Ding, C. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.774365 · Cited by 28
Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy
Hu, W., Davis, J. J., Zhu, H., Dong, F., Guo, W., Ang, J., Peng, H., Guo, Z. S., Bartlett, D. L., Swisher, S. G., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.11.4855 · Cited by 23
Self-citationJanelle, V., Langlois, M.-P., Lapierre, P., Charpentier, T., Poliquin, L., & Lamarre, A. (2014) · Molecular Therapy · doi:10.1038/mt.2014.34 · Cited by 19
Cited by
The role of necroptosis in cancer biology and therapy
Gong, Y., Fan, Z., Luo, G., Yang, C., Huang, Q., Fan, K., Cheng, H., Jin, K., Ni, Q., Yu, X., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1029-8 · Cited by 1,040
Coinhibitory Pathways in Immunotherapy for Cancer
Baumeister, S. H., Freeman, G. J., Dranoff, G., & Sharpe, A. H. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112049 · Cited by 910
Consensus guidelines for the detection of immunogenic cell death
Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.955691 · Cited by 832
Self-citationOncolytic virotherapy: basic principles, recent advances and future directions
Lin, D., Shen, Y., & Liang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01407-6 · Cited by 459
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Lei, Q., Wang, D., Sun, K., Wang, L., & Zhang, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00672 · Cited by 421
Metadata
- Authors
- Guo, Z. S., Liu, Z., & Bartlett, D. L.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2014-04-10
- Volume
- 4
- Pages
- 74-74
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W1967262248
- Cited by
- 284
- References
- 130
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.